ACUTE EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ON MONOAMINES IN RAT CAUDATE

被引:95
作者
GOUGH, B
ALI, SF
SLIKKER, W
HOLSON, RR
机构
[1] Division of Reproductive, Developmental Toxicology National Center for Toxicological Research, Jefferson
关键词
MDMA; CEREBRAL MICRODIALYSIS; DOPAMINE; SEROTONIN; CAUDATE NUCLEUS; FREELY-MOVING RATS; INTRACEREBRAL DIALYSIS; DOPAMINE RELEASE; STRIATAL DOPAMINE; NUCLEUS ACCUMBENS; BRAIN; AMPHETAMINE; METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN; INVIVO;
D O I
10.1016/0091-3057(91)90137-Q
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Extracellular levels of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and serotonin (5-HT) were assayed in the caudate of freely moving rats using microdialysis and high performance liquid chromatography with electrochemical detection (HPLC-EC) to detect changes in their release. Dialysates were assayed at 20-minute intervals for four hours after an intraperitoneal (IP) injection of MDMA (10 mg/kg). In a separate study to determine MDMA effects on total caudate levels of the above neurochemicals, animals were injected IP with MDMA (10 mg/kg) and then sacrificed at 20, 60, 120 and 180 minutes after treatment. Brains were quickly removed, and caudate nuclei were dissected for neurochemical analysis using HPLC-EC. MDMA elicited an amphetamine-like increase in DA release, followed by an increase in DA content. DOPAC and HVA were both reduced in homogenate. 5-HT release was also increased, followed by a drop in caudate homogenate levels by three hours. DA extracellular content was 686% of control at 80 minutes; caudate homogenate levels were 122% at 120 minutes. 5-HT extracellular release was 123% at 20 minutes, then decreased thereafter. It is concluded that the acute effect of MDMA on caudate is at least as great on the DA as it is on the 5-HT system.
引用
收藏
页码:619 / 623
页数:5
相关论文
共 27 条
[1]  
ALI SF, 1986, ACTA PHARMACOL TOX, V59, P179
[2]   LONG-TERM CHANGES IN DOPAMINERGIC INNERVATION OF CAUDATE-NUCLEUS AFTER CONTINUOUS AMPHETAMINE ADMINISTRATION [J].
ELLISON, G ;
EISON, MS ;
HUBERMAN, HS ;
DANIEL, F .
SCIENCE, 1978, 201 (4352) :276-278
[3]   LONG-LASTING DEPLETION OF STRIATAL DOPAMINE BY A SINGLE INJECTION OF AMPHETAMINE IN IPRINDOLE-TREATED RATS [J].
FULLER, RW ;
HEMRICKLUECKE, S .
SCIENCE, 1980, 209 (4453) :305-307
[4]   SIMULTANEOUS MICRODIALYSIS AND AMPHETAMINE INFUSION IN THE NUCLEUS ACCUMBENS AND STRIATUM OF FREELY MOVING RATS - INCREASE IN EXTRACELLULAR DOPAMINE AND SEROTONIN [J].
HERNANDEZ, L ;
LEE, F ;
HOEBEL, BG .
BRAIN RESEARCH BULLETIN, 1987, 19 (06) :623-628
[5]   ENANTIOMERIC DIFFERENCES IN THE EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE ON EXTRACELLULAR MONOAMINES AND METABOLITES IN THE STRIATUM OF FREELY-MOVING RATS - AN INVIVO MICRODIALYSIS STUDY [J].
HIRAMATSU, M ;
CHO, AK .
NEUROPHARMACOLOGY, 1990, 29 (03) :269-275
[6]   EFFECTS OF DOPAMINERGIC AND SEROTONERGIC RECEPTOR BLOCKADE ON NEUROCHEMICAL CHANGES INDUCED BY ACUTE ADMINISTRATION OF METHAMPHETAMINE AND 3,4-METHYLENEDIOXYMETHAMPHETAMINE [J].
JOHNSON, M ;
HANSON, GR ;
GIBB, JW .
NEUROPHARMACOLOGY, 1988, 27 (11) :1089-1096
[7]   EFFECTS OF THE ENANTIOMERS OF MDA, MDMA AND RELATED ANALOGS ON [H-3] SEROTONIN AND [H-3] DOPAMINE RELEASE FROM SUPERFUSED RAT-BRAIN SLICES [J].
JOHNSON, MP ;
HOFFMAN, AJ ;
NICHOLS, DE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 132 (2-3) :269-276
[8]   DIFFERENCES BETWEEN RATS AND MICE IN MDMA (METHYLENEDIOXYMETHYLAMPHETAMINE) NEUROTOXICITY [J].
LOGAN, BJ ;
LAVERTY, R ;
SANDERSON, WD ;
YEE, YB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 152 (03) :227-234
[9]   EFFECTS OF (+/-)3,4-METHYLENEDIOXY-METHAMPHETAMINE (MDMA) ON BRAIN DOPAMINERGIC ACTIVITY IN RATS [J].
MATTHEWS, RT ;
CHAMPNEY, TH ;
FRYE, GD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 33 (04) :741-747
[10]   EFFECTS OF CERTAIN HALLUCINOGENIC AMPHETAMINE ANALOGS ON THE RELEASE OF [H-3]-LABELED SEROTONIN FROM RAT-BRAIN SYNAPTOSOMES [J].
NICHOLS, DE ;
LLOYD, DH ;
HOFFMAN, AJ ;
NICHOLS, MB ;
YIM, GKW .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (05) :530-535